Pascal Touchon - 16 May 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Reporting relationship: President and CEO, Director
Issuer ticker: ATRA
Reported as of: 16 May 2024
Net transaction value: -$50,289
SEC form: 4
Accepted by SEC: 20 May 2024, 20:34:45 UTC
Prior SEC filing: 06 Mar 2024
Next SEC filing: 14 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ John Chao, Attorney-in-Fact for Pascal Touchon

Key filing fact

Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 20 May 2024.

Key facts

This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 May 2024, 20:34.

Change

Previous filing in this sequence was filed on 06 Mar 2024.
Current net transaction value: -$50,289.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATRA transaction

Common Stock

Sale

Transaction value: $50,289
Shares: -81,506
Change %: -4.3%
Price: $0.6170
Shares after: 1,829,146
Date: 16 May 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.

Footnote F2

The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2024 and May 17, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.